Some ALDH2*2 carriers continue to consume alcohol despite experiencing these adverse effects, placing them at higher risk for several diseases, including esophageal, head and neck, liver, and colorectal cancers, as well as cardiovascular disease (Chang et al., 2017; Chen et al., 2010). Here, ALDH2 is linked to colorectal cancer.